Prepared surface cells of the cornea of the eye.

 IPS cells have the ability to change from various cells (induced pluripotent stem cells), Osaka University research team has produced a corneal surface of the eye cells.
In the future, it may lead to treatments such as "Stevens-Johnson syndrome" incurable disease of unknown cause, such as vision loss occurs cloudy cornea surface.
23, from the research team of Professor and Assistant Professor Hayashi Nishida university was presented at the Japanese Society for Regenerative Medicine was held in Yokohama. Covering the surface of the cornea, the research team was prepared, "corneal epithelial cells", which help discourage the entry of pathogens such as bacteria. Make cells that induce changes such as adding a special protein to human iPS cells have a structure which is very similar to the corneal epithelial cells, cultured as I was in the shape of a (thin) sheet. I have confirmed the ability to transplant the eyes of rabbits this sheet to prevent pathogen. Various sites will be created through the cell iPS. Will wait for more and more clinical.



大阪大の研究チームが、様々な細胞に変化する能力を持つｉＰＳ細胞（人工多能性幹細胞）から、目の角膜表面の細胞を作製した。
　将来は、角膜表面がにごって視力低下などが起きる原因不明の難病「スティーブンス・ジョンソン症候群」などの治療につながる可能性があるという。
　同大の西田教授と林助教らの研究チームが２３日、横浜市で開かれた日本再生医療学会で発表した。研究チームが作製したのは、角膜表面を覆い、細菌など病原体の侵入を防いでいる「角膜上皮細胞」。人のｉＰＳ細胞に特殊なたんぱく質などを加え変化を誘導し、角膜上皮細胞と良く似た構造を持つ細胞を作って、シート（薄膜）の形状になるように培養した。このシートをウサギの目に移植し、病原体を防ぐ機能を確認した。様々な部位がiPS細胞を通じて作成されていきますね。臨床がますます待たれますね。